Regeneron Pharmaceuticals
REGN
#254
Rank
โ‚ฌ67.71 B
Marketcap
619,41ย โ‚ฌ
Share price
-0.78%
Change (1 day)
-29.71%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): 34,72ย โ‚ฌ

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 34,27ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 37,16ย โ‚ฌ a decrease over its 2021 EPS that were of 70,12ย โ‚ฌ.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)34,72ย โ‚ฌ-6.58%
202237,16ย โ‚ฌ-47%
202170,12ย โ‚ฌ133.36%
202030,05ย โ‚ฌ69.13%
201917,77ย โ‚ฌ-14.44%
201820,77ย โ‚ฌ100.71%
201710,35ย โ‚ฌ31.78%
20167,85ย โ‚ฌ38.96%
20155,65ย โ‚ฌ72.55%
20143,27ย โ‚ฌ-17.55%
20133,97ย โ‚ฌ-44.98%
20127,22ย โ‚ฌ-422.54%
2011-2,24ย โ‚ฌ92.13%
2010-1,16ย โ‚ฌ49.41%
2009-0,78ย โ‚ฌ-15.84%
2008-0,93ย โ‚ฌ-36.88%
2007-1,47ย โ‚ฌ-9.6%
2006-1,62ย โ‚ฌ4.12%
2005-1,56ย โ‚ฌ-323.68%
20040,70ย โ‚ฌ-135.51%
2003-1,96ย โ‚ฌ-24.38%
2002-2,60ย โ‚ฌ56.35%
2001-1,66ย โ‚ฌ187.3%
2000-0,58ย โ‚ฌ-8.57%
1999-0,63ย โ‚ฌ177.78%
1998-0,23ย โ‚ฌ-35.71%
1997-0,35ย โ‚ฌ-68.42%
1996-1,12ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
12,98ย โ‚ฌ-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-3,77ย โ‚ฌ-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
16,93ย โ‚ฌ-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
12,92ย โ‚ฌ-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
3,43ย โ‚ฌ-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
2,92ย โ‚ฌ-91.49%๐Ÿ‡ซ๐Ÿ‡ท France